Skip to main content
Gregory Kirk, MD, Infectious Disease, Baltimore, MD, Johns Hopkins Hospital

GregoryDaleKirkMD

Infectious Disease • Baltimore, MD

Dual Primary Appointment in Medicine & Epidemiology; Joint Appointment in Oncology

Join to view full profile

Dr. Kirk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kirk's full profile

Already have an account?

Summary

  • Dr. Gregory Kirk, MD, MPH, PhD is the Vice Dean for Research at the Johns Hopkins Bloomberg School of Public Health, and previously served as the Vice Chair for Clinical and Translational Research for the Department of Medicine in the Johns Hopkins School of Medicine. Dr. Kirk graduated from medical school at the University of Oklahoma and completed residency and fellowship training at Johns Hopkins, Georgetown University and the National Institutes of Health. He received his MPH and doctoral degrees in Epidemiology from Johns Hopkins, and now is a Professor in the Departments of Medicine, Epidemiology and Oncology.
    Dr. Kirk’s research focuses on understanding and ameliorating the overlapping epidemics of HIV and non-communicable diseases (NCDs) globally. He leads an interdisciplinary group of epidemiologists, clinicians, biostatisticians and behavioral and laboratory scientists involved in a diverse research portfolio in US and international settings (Africa, the Caribbean, the Netherlands). He initiated an NHLBI-funded consortium of Baltimore-based cohorts to longitudinally evaluate chronic pulmonary complications of HIV (SHIELD; Study of HIV Infection in the Etiology of Lung Disease). With >2,500 participants followed with collection of detailed respiratory surveys, biospecimens, and spirometry for 12 years, SHIELD is among the largest and longest running prospective cohorts of lung disease focused on HIV. As Principal Investigator, Dr. Kirk has received >$50 million in NIH grant funding from 6 different NIH institutes. He has contributed to >275 peer-reviewed publications and is an elected Fellow of the Infectious Diseases Society of America, the American College of Epidemiology and American Society of Clinical Investigation. Board-certified in preventive medicine, internal medicine, and infectious diseases, Dr. Kirk maintains certification and continues clinical practice in infectious diseases at Johns Hopkins Hospital and Hopkins Bayview Medical Center.

Education & Training

  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Infectious Diseases @ NIAID, 2004
  • Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public HealthResidency, Public Health and General Preventive Medicine, 1994 - 1997
  • University of Oklahoma College of Medicine
    University of Oklahoma College of MedicineClass of 1993
  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterInternship, Internal Medicine
  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalResidency, Internal Medicine

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 1999 - Present
  • IL State Medical License
    IL State Medical License 2021 - 2026
  • PA State Medical License
    PA State Medical License 2004 - 2024
  • MD State Medical License
    MD State Medical License 1994 - 2024
  • CO State Medical License
    CO State Medical License 2022 - 2023
  • AL State Medical License
    AL State Medical License 2022 - 2022
  • VA State Medical License
    VA State Medical License 1999 - 2010
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Association Between HIV Infection and Mitochondrial DNA Copy Number in Peripheral Blood: A Population-Based, Prospective Cohort Study  
    Todd T Brown, Shruti H Mehta, Gregory D Kirk, The Journal of Infectious Diseases

Press Mentions

  • Advancing Knowledge of HIV Impact on Hepatitis C Infection and Genes That May Thwart HCV
    Advancing Knowledge of HIV Impact on Hepatitis C Infection and Genes That May Thwart HCVFebruary 10th, 2016

Grant Support

  • Natural History Of HIV Infection In Injection Drug UsersNational Institute On Drug Abuse2007–2011
  • The Study Of HIV Infection In The Etiology Of Lung Disease (SHIELD)National Heart, Lung, And Blood Institute2007–2011
  • Epidemiology And Mechanisms Of Accelerated Aging In HIV InfectionNational Institute Of Allergy And Infectious Diseases2009–2010
  • REAL Time Methods For Quantifying Exposure To Illicit Drugs &Psychosocial StressNational Institute On Drug Abuse2007–2010
  • Natural History Of HIV Infection In Injection Drug UsersNational Institute On Drug Abuse2006

Hospital Affiliations

Dr. Gregory Kirk, Dr. Gregory Kirk, MD, Dr. G Kirk, Dr. Gregory Dale Kirk